API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

Minoxidil sulphate: History and Pharmacokinetics

Minoxidil sulphate, approved for hypertension, later found use in treating baldness due to hypertrichosis. Its absorption and metabolism inform treatment optimization.

Mar 28,2024  API

The refinement of the crystal structure of skutterudite, CoAs3

The crystal structure of skutterudite, cobalt triarsenide, has been re-refined with new data collected at 22 °C on a Picker automatic diffractometer (Mo Ke) out to a maximum sin 0/).=0.60, with the mo

Mar 27,2024  API

Gadolinium oxide: Single crystals and Structural motifs for diferent phases

Structural motifs for diferent phases of Gd2O3. a–d Hexagonal, monoclinic, cubic and tetragonal phases, respectively. The pink and red spheres indicate gadolinium (Gd) and oxygen (O) atoms, respective

Mar 27,2024  API

What does letrozole do for breast cancer?

Femara (chemical name: letrozole) is an aromatase inhibitor used to treat all stages of hormone receptor-positive breast cancer in post-menopausal women.

Mar 27,2024  API

Dicyclohexylcarbodiimide(DCC) vs 4-(Dimethylamino)pyridine(DMAP): the difference between the two

Although both DCC and DMAP are used in chemical synthesis, there are differences in their applications.

Mar 27,2024  API

Exploring Bremelanotide: The Science Behind the Promising Drug

Bremelanotide is a peptide drug with the potential to address sexual dysfunction.

Mar 27,2024  API

Exploring the Significance of Barium Chemistry in Soil Distribution and Plant Uptake

Barium chemistry studies its reactivity, distribution in soils, uptake by plants, and environmental impact for industrial and ecological relevance.

Mar 27,2024  API

11,12-Dihydroindolo[2,3-a]carbazole: Overview, Preparation Method and Applications in Anion Complexation and Sensing

11,12-Dihydroindolo[2,3-a]carbazole, with its unique structure, offers potential in anion complexation and sensing, showing promise in scientific exploration and advancements in sensor technology.

Mar 27,2024  API

Pepto-Bismol and Tum

Both Pepto-Bismol and Tums have antacid effects, which help neutralize stomach acid.

Mar 26,2024  API

Fludarabine, cyclophosphamide and rituximab (FCR)

Combining fludarabine, cyclophosphamide, and rituximab (FCR) is a widely used CIT regimen for CLL

Mar 26,2024  API
Prev12345678910...Next>  Go to Page